Fennec Pharmaceuticals Inc. (TSX:FRX)
Canada · Delayed Price · Currency is CAD 10.50
-0.04 (-0.33%)
Feb 11, 2026, 12:12 PM EST
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 32 employees as of December 31, 2024. The number of employees increased by 3 or 10.34% compared to the previous year.
Employees
32
Change (1Y)
3
Growth (1Y)
10.34%
Revenue / Employee
1.69M CAD
Profits / Employee
-302.04K CAD
Market Cap
360.16M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 32 | 3 | 10.34% |
| Dec 31, 2023 | 29 | -7 | -19.44% |
| Dec 31, 2022 | 36 | 26 | 260.00% |
| Dec 31, 2021 | 10 | 1 | 11.11% |
| Dec 31, 2020 | 9 | 5 | 125.00% |
| Mar 31, 2020 | 5 | 2 | 66.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Eupraxia Pharmaceuticals | 33 |
| Bright Minds Biosciences | 26 |
| Medicenna Therapeutics | 18 |
| Satellos Bioscience | 17 |
| Sernova Biotherapeutics | 8 |
| Helix BioPharma | 7 |
Fennec Pharmaceuticals News
- 4 weeks ago - Piper Sandler Initiates Coverage on Fennec Pharmaceuticals (FENC) | FENC Stock News - GuruFocus
- 6 weeks ago - Southpoint Capital Advisors LP Reduces Stake in Fennec Pharmaceuticals Inc - GuruFocus
- 6 weeks ago - Southpoint Capital Reduces Stake in Fennec Pharmaceuticals (FENC) - GuruFocus
- 6 weeks ago - Southpoint sells $7.5M worth stock of Fennec Pharmaceuticals - Seeking Alpha
- 6 weeks ago - Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - GlobeNewsWire
- 7 weeks ago - Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 - Seeking Alpha
- 2 months ago - Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss - GlobeNewsWire